SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject9/18/2002 10:30:45 AM
From: nigel bates   of 1022
 
WESTBOROUGH, Mass., Sept. 18 /PRNewswire/ -- Now in it's 13th year, IBC's Antibody Engineering Conference will be held December 1-4, 2002, at the Paradise Point Resort in San Diego, CA. This valuable conference features the latest technologies and applications in this fast growing field. www.LifeSciencesInfo.com/antibodyeng.
No other antibody meeting delivers the quality and quantity of unpublished research, internationally recognized scientists, poster and networking opportunities and as complete an exhibit hall. This year's event begins with a pre-conference colloquium on antibody engineering and array technology for functional genomcis/proteomics. Following that is an evening forum, on deal- making and partnering in the antibody engineering field. This forum is a first ever for this event, providing an overview of the business status of the antibody sector and the opportunities available for deal-making from both the pharmaceutical industry and the investment community.
The main conference opens on Monday morning, December 2 with a keynote address by Dr. Ian A Wilson, Professor, Molecular Biology, at The Scripps Research Institute on the structural basis of antigen recognition in the immune system. Additional highlights include presentations on structural immunology, display technologies for ligand generation, immunotherapeutics of recombinant antibodies, recombinant antibodies in infectious disease, preclinical optimization of engineered antibodies, and targeting in cellular and genetic therapy. Over 60 of the leading experts will report on the their latest findings and attendees will have the opportunity to network with over 600 researchers in this field.
The event is sponsored by IBC Life Sciences, part of Informa, plc (London: INF), a leading provider in the exchange of scientific, business and technical information through conferences, publications, and electronic media. For more information or to register online, visit the event website, www.LifeSciencesInfo.com/antibodyeng.
Contact:
Julie Anderson
IBC USA Conferences, Inc.
One Research Drive
Suite 400A
Westborough, MA 01581
Tel: 508 616-5550
Fax: 508 616-5533
mailto: janderson@ibcusa.com

------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext